0.980
-0.01 (-1.01%)
Penutupan Terdahulu | 0.990 |
Buka | 0.985 |
Jumlah Dagangan | 4,211 |
Purata Dagangan (3B) | 242,214 |
Modal Pasaran | 169,290,096 |
Harga / Pendapatan (P/E TTM) | 19.60 |
Harga / Pendapatan (P/E Ke hadapan) | 22.47 |
Harga / Jualan (P/S) | 2.55 |
Harga / Buku (P/B) | 2.70 |
Julat 52 Minggu | |
Tarikh Pendapatan | 22 Aug 2024 |
Margin Keuntungan | 12.55% |
Margin Operasi (TTM) | 19.73% |
EPS Cair (TTM) | 0.050 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 11.30% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -1.80% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 1.64% |
Nisbah Semasa (MRQ) | 3.45 |
Aliran Tunai Operasi (OCF TTM) | 5.78 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 2.50 M |
Pulangan Atas Aset (ROA TTM) | 6.89% |
Pulangan Atas Ekuiti (ROE TTM) | 13.87% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Health Information Services (AU) | Bercampur | Bercampur |
Health Information Services (Global) | Bercampur | Menurun | |
Stok | COGSTATE FPO [CGS] | - | - |
AISkor Stockmoo
Konsensus Penganalisis | 0.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 4.5 |
Purata Bergerak Teknikal | -2.5 |
Osilator Teknikal | 3.5 |
Purata | 1.38 |
Cogstate Ltd is a cognitive science company. The principal activity of the group is Creation, validation and commercialisation of digital brain health assessments; and Design and provision of quality assurance services in clinical trials, focused on the administration, scoring and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials; Healthcare and Research. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services. |
|
Sektor | Healthcare |
Industri | Health Information Services |
Gaya Pelaburan | Small Growth |
% Dimiliki oleh Orang Dalam | 42.23% |
% Dimiliki oleh Institusi | 22.22% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |